Search results
Psychedelic-medicine stocks drop after ecstasy's rocky day at the FDA
Morningstar· 22 hours agoPsychedelic-medicine stocks dropped sharply early Wednesday, a day after an independent panel of Food and Drug Administration advisers said the benefits of MDMA-assisted therapy for post-traumatic ...
FDA panel to review psychedelic drug MDMA for first time
KSL Salt Lake City· 2 days agoThe meeting by the agency's independent experts is the farthest that a drug based on MDMA, commonly...
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
Medscape· 2 days agoThe Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug...
FDA urged to relax decades-old tissue donation restrictions for gay and bisexual men
Denver Post· 4 days agoAt least one senior FDA official has indirectly agreed. Peter Marks, who directs the FDA’s Center...
New report reveals concerning levels of contaminant found in products of several popular olive oil...
The Cool Down via Yahoo News· 19 hours agoWhat's also alarming is that while some phthalates are restricted in children's products, the Food...
FDA reviews MDMA for PTSD treatment; Biden to issue executive order on border policy
WUSF 89.7· 2 days agoA panel of FDA experts starts reviewing clinical trial data today to decide whether to approve the...
FDA panel to review psychedelic drug MDMA for first time
WSAU Wausau· 2 days agoBy Sriparna Roy and Pratik Jain (Reuters) - A panel of advisers to the U.S. Food and Drug...
Over 1,000 Black Market Ozempic Injections Seized by Federal Agents in Cincinnati
Cincinnati CityBeat· 14 hours agoSince becoming a sought-after drug for weight loss, the type 2 diabetes medication Ozempic has...
Why is the "Right to Contraception Act" considered necessary?
NBC News via Yahoo News· 21 hours ago“In the face of that, we are innovating to make sure that people have what they need when they...
Lykos Therapeutics Provides Update on FDA Advisory Committee Meeting for Investigational...
The Record Gazette· 2 days agoSAN JOSE, Calif., June 4, 2024 /PRNewswire/ -- Lykos Therapeutics ("Lykos"), a company dedicated to transforming mental healthcare, announced the outcome of the U.S. Food and Drug Administration's ("FDA") Psychopharmacologic